In this free webinar, gain insight into how model-informed drug development uses early PK/PD data, extrapolation and simulation to enable earlier, regulator-ready pediatric dose selection with fewer ...
Looser regulations around consumer-grade wearable devices could be a "path to ROI" for health systems—or a "double-edged ...
Curious about how protein crystallography fits into modern drug discovery? In this on-demand webinar, Dr. Thomas Pesnot from Concept Life Sciences chats with Dr. Debanu Das of Accelero Biostructure, ...
FDA Accepts Investigational New Drug (IND) Application for COMP360 for the treatment of post-traumatic stress disorder (PTSD), enabling initiation of late-stage trial Compass continues to advance ...
This webinar explores how liver microphysiological systems support toxicology from early screening to species-specific risk ...
Leveraging biologics manufacturing capacity to supply life-improving or life-saving medicines is key to a flexible supply chain that can respond to unforeseen demand changes. This webinar examines how ...
As employers continue to navigate evolving workplace challenges, the webinar will focus on the meaning of a drug-free workplace in 2026, including prevention strategies, policy considerations, and the ...
LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announced that the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results